首页 › 膀胱癌 › 纽约州 › New York City

New York City NY 膀胱癌临床试验

35项针对膀胱癌的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。

官方研究文本（英文）

正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

招募中2 期

Memorial Sloan Kettering Cancer Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT06770582

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

招募中3 期

Veterans Affairs New York Harbor Healthcare System-Manhattan Campus, New York
Memorial Sloan Kettering Cancer Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07000084

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

招募中1 期

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
以及另外 2 项

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT06465069

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

招募中1/2 期

Memorial Sloan Kettering Cancer Center ( Site 5031), New York

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07232602

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

招募中观察性研究欢迎健康志愿者

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

招募中2 期

Memorial Sloan Kettering Hospital, New York

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06172478

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

招募中2 期

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

招募中2 期

NYP/Weill Cornell Medical Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

招募中2 期

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
NYP/Weill Cornell Medical Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

招募中1/2 期

Icahn School of Medicine at Mount Sinai, New York

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

招募中1 期

Columbia University Irving Medical Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07277413

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

招募中1 期

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
Memorial Sloan Kettering Cancer Center 53rd street, New York
Icahn School of Medicine at Mount Sinai, New York
以及另外 3 项

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07206225

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

招募中3 期

Memorial Sloan Kettering Cancer Center ( Site 0832), New York

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07419295

A Study of Surgical Techniques During Cystectomy

招募中3 期

Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York

21 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06703476

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

招募中3 期

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

招募中1 期

Icahn School of Medicine at Mount Sinai, New York
Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年9月15日 · NCT07217171

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

招募中1 期

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年9月4日 · NCT06644755

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

招募中2 期

Integrated Medical Professionals, PLLC (Solaris), New York

18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT06567743

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

招募中

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

18 岁及以上 · 所有性别 · 更新于 2026年9月2日 · NCT05837767

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

招募中2 期

Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York

18 岁及以上 · 所有性别 · 更新于 2026年8月24日 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

招募中1 期

New York University (NYU), New York
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
以及另外 2 项

18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

招募中3 期

Memorial Sloan Kettering Cancer Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年8月18日 · NCT07097142

A Study of a Side Effects and Resource Navigation Program for People With Cancer

招募中

City College of New York (Data Collection AND Specimen Analysis), New York
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

18 岁及以上 · 所有性别 · 更新于 2026年7月31日 · NCT07646847

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

招募中2/3 期

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年7月29日 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

招募中2 期

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

8 岁及以上 · 所有性别 · 更新于 2026年7月27日 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

招募中2 期

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
Icahn School of Medicine at Mount Sinai, New York
Evelyn H. Lauder Breast and Imaging Centre (BAIC), New York
以及另外 2 项

18 岁及以上 · 所有性别 · 更新于 2026年7月22日 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

招募中3 期

Research Site, New York

18 岁及以上 · 所有性别 · 更新于 2026年7月22日 · NCT07720284

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

招募中1 期

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Columbia University Irving Medical Center, New York

18 岁及以上 · 所有性别 · 更新于 2026年7月6日 · NCT04389632